Stuart Goldstein

Dr. Goldstein is an active investigator in the field of pediatric acute kidney injury (AKI) since 2000. His main research foci include AKI epidemiology and outcomes, acute renal replacement therapy provision, and investigation of novel urinary AKI biomarkers in the pediatric population. He has a strong record of interdisciplinary and inter-institutional collaboration, evidenced by my establishment and directing of the Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry and its success as well as collaboration with critical care physicians, cardiologists, and emergency medicine physicians to study AKI in their populations. More recently, he established the Prospective Pediatric AKI Research Group (www.ppaki.org), a 53 international research consortium with a mission of advancing translational science for children with AKI. The ppAKI recently published an unprecedented prospective observational study, Assessment of Worldwide AKI, Renal Angina and Epidemiology (AWARE – NCT01987921).AWARE enrolled 5,927 patients from 32 centers worldwide, making it the largest pediatric critical care nephrology study executed to date. He was recruited to Cincinnati Children’s Hospital in 2010 to establish and direct the Center for Acute Care Nephrology (CACN), which has as one of its aims to collaborate with investigators throughout the world to improve outcomes for children with or at-risk for AKI.